# Atlantic Union Bankshares Corp: financial statements, quarterly

AUB · NYSE · CIK 883948 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/aub.md) · [Financials](/companies/aub/financials.md) · [Filings](/companies/aub/filings.md) · [Insiders](/companies/aub/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/aub/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Interest expense | $m | [95.2](/filings/0000883948-23-000102.md) | [106 d](/filings/0000883948-24-000030.md) | [115](/filings/0000883948-24-000047.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [11.5](/filings/0000883948-24-000095.md) | [10.0 d](/filings/0000883948-26-000021.md) | [10.1](/filings/0000883948-25-000046.md) | [11.4](/filings/0000883948-25-000090.md) | [15.6](/filings/0000883948-25-000108.md) | [13.5 d](/filings/0000883948-26-000021.md) | [11.7](/filings/0000883948-26-000047.md) | [(2.3)](/filings/0000883948-26-000073.md) | [24.1](/filings/0000883948-25-000108.md) | [29.7 d](/filings/0000883948-26-000021.md) | [32.4](/filings/0000883948-26-000047.md) | [43.5](/filings/0000883948-26-000073.md) |
| Net income | $m | [54.0](/filings/0000883948-24-000095.md) | [56.9 d](/filings/0000883948-26-000021.md) | [49.8](/filings/0000883948-25-000108.md) | [25.2](/filings/0000883948-25-000108.md) | [76.4](/filings/0000883948-25-000108.md) | [57.8 d](/filings/0000883948-26-000021.md) | [49.8](/filings/0000883948-26-000073.md) | [19.8](/filings/0000883948-26-000073.md) | [92.1](/filings/0000883948-25-000108.md) | [112 d](/filings/0000883948-26-000021.md) | [122](/filings/0000883948-26-000073.md) | [161](/filings/0000883948-26-000073.md) |
| Diluted EPS | $ per share | [0.68](/filings/0000883948-24-000095.md) | not reported | [0.62](/filings/0000883948-25-000046.md) | [0.25](/filings/0000883948-25-000090.md) | [0.82](/filings/0000883948-25-000108.md) | not reported | [0.52](/filings/0000883948-26-000047.md) | [0.12](/filings/0000883948-26-000073.md) | [0.63](/filings/0000883948-25-000108.md) | not reported | [0.84](/filings/0000883948-26-000047.md) | [1.11](/filings/0000883948-26-000073.md) |
| Basic EPS | $ per share | [0.68](/filings/0000883948-24-000095.md) | not reported | [0.62](/filings/0000883948-25-000046.md) | [0.25](/filings/0000883948-25-000090.md) | [0.82](/filings/0000883948-25-000108.md) | not reported | [0.53](/filings/0000883948-26-000047.md) | [0.12](/filings/0000883948-26-000073.md) | [0.63](/filings/0000883948-25-000108.md) | not reported | [0.84](/filings/0000883948-26-000047.md) | [1.11](/filings/0000883948-26-000073.md) |

- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [0.4](/filings/0000883948-23-000102.md) | [0.4](/filings/0000883948-25-000021.md) | [0.4](/filings/0000883948-24-000047.md) | [0.4](/filings/0000883948-24-000082.md) | [0.5](/filings/0000883948-24-000095.md) | [0.4](/filings/0000883948-26-000021.md) | [0.4](/filings/0000883948-25-000046.md) | [1.6](/filings/0000883948-25-000090.md) | [0.8](/filings/0000883948-25-000108.md) | [1.0](/filings/0000883948-26-000073.md) | [0.8](/filings/0000883948-26-000047.md) | [1.0](/filings/0000883948-26-000073.md) |
| Total assets | $bn | [20.7](/filings/0000883948-23-000102.md) | [21.2](/filings/0000883948-25-000021.md) | [21.4](/filings/0000883948-24-000047.md) | [24.8](/filings/0000883948-24-000082.md) | [24.8](/filings/0000883948-24-000095.md) | [24.6](/filings/0000883948-26-000021.md) | [24.6](/filings/0000883948-25-000046.md) | [37.3](/filings/0000883948-25-000090.md) | [37.1](/filings/0000883948-25-000108.md) | [37.6](/filings/0000883948-26-000073.md) | [37.3](/filings/0000883948-26-000047.md) | [38.1](/filings/0000883948-26-000073.md) |
| Total liabilities | $bn | [18.3](/filings/0000883948-23-000102.md) | [18.6](/filings/0000883948-25-000021.md) | [18.8](/filings/0000883948-24-000047.md) | [21.7](/filings/0000883948-24-000082.md) | [21.6](/filings/0000883948-24-000095.md) | [21.4](/filings/0000883948-26-000021.md) | [21.4](/filings/0000883948-25-000046.md) | [32.5](/filings/0000883948-25-000090.md) | [32.2](/filings/0000883948-25-000108.md) | [32.6](/filings/0000883948-26-000073.md) | [32.3](/filings/0000883948-26-000047.md) | [32.9](/filings/0000883948-26-000073.md) |
| Long-term debt | $bn | [0.4](/filings/0000883948-23-000102.md) | [0.4](/filings/0000883948-25-000021.md) | [0.4](/filings/0000883948-24-000047.md) | [0.4](/filings/0000883948-24-000082.md) | [0.4](/filings/0000883948-24-000095.md) | [0.4](/filings/0000883948-26-000021.md) | [0.4](/filings/0000883948-25-000046.md) | [0.8](/filings/0000883948-25-000090.md) | [0.8](/filings/0000883948-25-000108.md) | [0.8](/filings/0000883948-26-000073.md) | [0.8](/filings/0000883948-26-000047.md) | [0.8](/filings/0000883948-26-000073.md) |
| Short-term borrowings | $bn | [0.6](/filings/0000883948-23-000102.md) | [0.9](/filings/0000883948-25-000021.md) | [0.7](/filings/0000883948-24-000047.md) | [0.8](/filings/0000883948-24-000082.md) | [0.4](/filings/0000883948-24-000095.md) | [0.1](/filings/0000883948-26-000021.md) | [0.1](/filings/0000883948-25-000046.md) | [0.1](/filings/0000883948-25-000090.md) | [0.1](/filings/0000883948-25-000108.md) | [0.7](/filings/0000883948-26-000073.md) | [0.5](/filings/0000883948-26-000047.md) | [1.1](/filings/0000883948-26-000073.md) |
| Shareholders' equity | $bn | [2.4](/filings/0000883948-24-000095.md) | [2.6](/filings/0000883948-26-000021.md) | [2.5](/filings/0000883948-25-000108.md) | [3.0](/filings/0000883948-25-000108.md) | [3.2](/filings/0000883948-25-000108.md) | [3.1](/filings/0000883948-26-000073.md) | [3.2](/filings/0000883948-26-000073.md) | [4.8](/filings/0000883948-26-000073.md) | [4.9](/filings/0000883948-25-000108.md) | [5.0](/filings/0000883948-26-000073.md) | [5.1](/filings/0000883948-26-000073.md) | [5.2](/filings/0000883948-26-000073.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [89.4 d](/filings/0000883948-24-000095.md) | [53.3 d](/filings/0000883948-26-000021.md) | [57.0](/filings/0000883948-25-000046.md) | [85.6 d](/filings/0000883948-25-000090.md) | [67.5 d](/filings/0000883948-25-000108.md) | [98.3 d](/filings/0000883948-26-000021.md) | [62.0](/filings/0000883948-26-000047.md) | [1,904 d](/filings/0000883948-26-000073.md) | [157 d](/filings/0000883948-25-000108.md) | [114 d](/filings/0000883948-26-000021.md) | [127](/filings/0000883948-26-000047.md) | [150 d](/filings/0000883948-26-000073.md) |
| Dividends paid | $m | [22.5 d](/filings/0000883948-23-000102.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Share repurchases | $m | [0.0 d](/filings/0000883948-23-000102.md) | [0.0 d](/filings/0000883948-25-000021.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [74.7](/filings/0000883948-23-000102.md) | [74.8](/filings/0000883948-24-000047.md) | [75.0](/filings/0000883948-24-000082.md) | [75.0](/filings/0000883948-24-000095.md) | [75.2](/filings/0000883948-25-000046.md) | [89.8](/filings/0000883948-25-000090.md) | [89.8](/filings/0000883948-25-000108.md) | [90.1](/filings/0000883948-26-000047.md) | [142](/filings/0000883948-26-000073.md) | [142](/filings/0000883948-25-000108.md) | [142](/filings/0000883948-26-000047.md) | [142](/filings/0000883948-26-000073.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 142,814,896 at 2026-07-30, from the cover of the [10-Q filed 2026-08-06](/filings/0000883948-26-000073.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:27 ET. No prices; not investment advice.